SCHEMBL5313903

SCHEMBL5313903

Cc1cc2cc(NN)ccc2c(=O)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.54
▸ GAA P10253 4/20 0.54
▸ PARP1 P09874 2/20 0.42
▸ ADORA1 P30542 2/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ CDC25B P30305 5/20 0.40
▸ SAE1 Q9UBE0 4/20 0.40
▸ UBA2 Q9UBT2 4/20 0.40
▸ UBE2I P63279 2/20 0.40
▸ TDP2 O95551 2/20 0.36
▸ CASP6 P55212 2/20 0.36
▸ PPP1CA P62136 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ HPGD P15428 5/20 0.34
▸ MAPT P10636 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ THRB P10828 3/20 0.34
▸ APAF1 O14727 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL824579 0.77 KDM4E (0.63) KDM4EGAAPARP1ADORA1ADORA2A
SCHEMBL14243195 0.74 KDM4E (0.59) KDM4EGAAPARP1ADORA1ADORA2A
SCHEMBL5313894 0.74 KDM4E (0.59) KDM4EGAAPARP1CDC25BSAE1
SCHEMBL392734 0.74 GAA (0.59) KDM4EGAAPARP1ADORA1CDC25B
SCHEMBL5313969 0.72 ROCK2 (0.52) PARP1
SCHEMBL741856 0.71 AXL (0.59) KDM4EGAACDC25BTDP2CASP6
SCHEMBL29488099 0.71 KDM4E (1.00) KDM4EGAAPARP1CDC25BSAE1
SCHEMBL824574 0.71 KDM4E (1.00) KDM4EGAAPARP1CDC25BSAE1
SCHEMBL25070895 0.70 KDM4E (0.57) KDM4EGAAPARP1ALDH1A1HPGD
SCHEMBL3277310 0.67 HSD17B10 (0.46) KDM4EALDH1A1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 — — WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C KDM4E 3529/4885GAA 3571/4885PARP1 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback